Navigation Links
Trubion Presents Preclinical Data on Its SCORPION(TM) Multispecific Therapeutics at the 2009 American Association of Cancer Research Annual Meeting
Date:4/22/2009

outcome thereof. These statements are based on current expectations and assumptions regarding future events and business performance and involve certain risks and uncertainties that could cause actual results to differ materially. These risks include, but are not limited to, risks associated with the development of SCORPION multispecific therapeutics, the clinical advancement of TRU-016, the company's Wyeth collaboration, including Wyeth's control over development timelines, the risks that the Company is unable to advance its clinical development programs and regulatory applications and action at the rate it expects, and such other risks as identified in the company's annual report on Form 10-K for the period ended December 31, 2008, and from time to time in other reports filed by Trubion with the U.S. Securities and Exchange Commission. These reports are available on the Investors page of the company's corporate Web site at http://www.trubion.com. Trubion undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.

    Contact:
    Jim DeNike
    Senior Director, Corporate Communications
    Trubion Pharmaceuticals, Inc.
    (206) 838-0500
    jdenike@trubion.com
   http://www.trubion.com

    Waggener Edstrom Worldwide Healthcare
    Amy Petty
    Senior Account Executive
    (617) 576-5788
    amyp@waggeneredstrom.com

TRBN-SCORP


'/>"/>
SOURCE Trubion Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Trubion Pharmaceuticals, Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Systemic Lupus Erythematosus (SLE)
2. Trubion Pharmaceuticals Inc. Announces Work-Force Reductions and Restructuring
3. Trubion Announces Presentations at Upcoming Investor Conferences
4. Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results
5. Trubion Announces Presentations at Upcoming Investor Conferences
6. Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis
7. Trubion Pharmaceuticals Wins Patent Opposition - Genentech / Biogen Idec European Patent Revoked
8. Trubion Pharmaceuticals to Present at Fall 2008 Morgan Stanley Global Healthcare Unplugged Conference in New York
9. Trubion Pharmaceuticals to Present at the 7th Annual Needham & Company Biotechnology & Medical Technology Conference
10. Trubion Announces Presentations at April/May Investor Conferences
11. Trubion Pharmaceuticals Inc. Reports Fourth-Quarter and Year-Ended 2007 Financial Results and Provides 2008 Financial Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... , August 1, 2014 According ... Research "Biophotonics Market - Global Industry Analysis, Size, Share, ... was valued at USD 25.16 billion in 2013, which ... growing at a CAGR of 10.4% from 2014 to ... at  http://www.transparencymarketresearch.com/biophotonics-market.html Increasing demand for accurate ...
(Date:8/1/2014)... , Aug. 1, 2014 ... the launch of "Data InPress" ( http://glencoesoftware.com/data-inpress.html ... for integrating multidimensional image data into on-line ... application and Video Injection Service. ... - http://photos.prnewswire.com/prnh/20140731/132409 ...
(Date:7/31/2014)... 2014 Nearly 20,000 medical professionals and healthcare ... & Clinical Lab Expo in Chicago ... in diagnostic research and technology that will advance medicine ... As of Wednesday, July 30, more than 19,500 attendees ... Clinical Lab Expo, with more than 10,000 of these ...
(Date:7/31/2014)... -- Chemists at Indiana University Bloomington have described ... fashion, a development with potential value for the ... transistors and photovoltaic cells. , Their paper, "Anion-Induced ... Solids and 2D Self-Assembled Crystals," has been published ... of the Royal Society of Chemistry. It is ...
Breaking Biology Technology:Global Biophotonics Market is Expected to Reach USD 50.20 Billion in 2020: Transparency Market Research 2Global Biophotonics Market is Expected to Reach USD 50.20 Billion in 2020: Transparency Market Research 3Global Biophotonics Market is Expected to Reach USD 50.20 Billion in 2020: Transparency Market Research 4Glencoe Software Launches Data InPress 2Glencoe Software Launches Data InPress 3Research on Digital Health, Alzheimer's, Ebola Draws Nearly 20,000 Attendees to 2014 AACC Annual Meeting & Clinical Lab Expo 2Research on Digital Health, Alzheimer's, Ebola Draws Nearly 20,000 Attendees to 2014 AACC Annual Meeting & Clinical Lab Expo 3Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 2Chemists demonstrate 'bricks-and-mortar' assembly of new molecular structures 3
... /Xinhua-PRNewswire-FirstCall/ -- China Agritech, Inc.,(OTC Bulletin Board: CAGC) ... fertilizer manufacturer in China, today announced that it,has ... a subsidiary of AL Ezz,Group, a distributor of ... Africa, AL Ezz Group began working with ...
... CellCyte Genetics,Corporation (CellCyte) (OTC Bulletin Board: CCYG) ... investment and financial advice and,services. CellCyte seeks to ... technologies and will work with InCap to initiate ... of,CellCyte,s cell expander and stem cell delivery technologies., ...
... and pharmaceutical firms are developing a host of ... discovery process, reports Genetic Engineering and Biotechnology ... rely on a combination of high-throughput screening methods, ... an article in the July issue ( http://www.genengnews.com/articles/chitem.aspx?aid=2527 ...
Cached Biology Technology:China Agritech to Export Products to Egypt 2China Agritech to Export Products to Egypt 3CellCyte Genetics Retains InCap Group to Advise on Business Strategy and Financing 2CellCyte Genetics Retains InCap Group to Advise on Business Strategy and Financing 3CellCyte Genetics Retains InCap Group to Advise on Business Strategy and Financing 4
(Date:8/1/2014)... causes them at the molecular level is even more ... the most detailed map to date of a region ... such as age-related macular degeneration. The high-resolution molecular map ... blood and oxygen to the outer retina, itself critical ... proteins in different areas of the choroid, the researchers ...
(Date:8/1/2014)... 1, 2014Biologists at The Scripps Research Institute (TSRI) have ... calorie-burning process in brown fat cells. , The ... Edition of the Proceedings of the National Academy ... as "brown fat thermogenesis," which is of great interest ... and may also protect against diabetes. , "This finding ...
(Date:7/31/2014)... prestin was found to be a key gene responsible for ... the hair cells of the inner ear that contracts and ... an antique phonograph horn, amplify sound waves to make hearing ... in the advanced online edition of Molecular Biology and ... has also independently evolved to play a critical role in ...
Breaking Biology News(10 mins):A map for eye disease 2Scripps Research Institute scientists find new calorie-burning switch in brown fat 2Scripps Research Institute scientists find new calorie-burning switch in brown fat 3
... Researchers from the University of Michigan Comprehensive Cancer ... 90 percent of pancreatic cancers, the most deadly type ... Group D Complementing gene, called ATDC, is on average ... cells from a normal pancreas. What,s more, the gene ...
... geneticist Stephen Moose has developed a corn plant with enormous ... good silage, Moose said, due to a greater number of ... good energy crop. The gene known as Glossy 15 ... a waxy coating that acts like a sun screen for ...
... preschooler who,s avoiding their vegetables? A new Cornell University study ... Vision Carrots and Tomato Bursts left preschoolers asking for ... "X-ray Vision Carrots" ate nearly twice as much as they ... as "carrots." The Robert Wood Johnson-funded study also showed the ...
Cached Biology News:U-M researchers ID gene involved in pancreatic cancer 2Doubling a gene in corn results in giant biomass 2
Recombinant Rhesus Macaque IFN-alpha...
chk 1 kinase...
...
KNP-1 (HES1) Purified Anti-Mouse, Anti-Rat, Anti-Human, Anti-Dog, Anti-Chicken clone 35, Isotype Mouse IgG 1 , 150 µg Consult technical datasheet for details....
Biology Products: